First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia.
Ngula MondeMusso MunyemeGershom ChongweJonas Johansson WensmanMildred ZuluSeter SiziyaRabecca TemboKabengele K SiameObi ShambabaSydney MalamaPublished in: Antibiotics (Basel, Switzerland) (2023)
This study has established a high rate of multidrug-resistant TB and has further identified both pre-XDR- and XDR-TB. There is a need to intensify surveillance of MDR- and XDR-TB to inform future guidelines for effective treatment and monitoring.
Keyphrases
- mycobacterium tuberculosis
- pulmonary tuberculosis
- multidrug resistant
- drug resistant
- end stage renal disease
- newly diagnosed
- gram negative
- chronic kidney disease
- public health
- prognostic factors
- peritoneal dialysis
- klebsiella pneumoniae
- escherichia coli
- clinical practice
- pseudomonas aeruginosa
- combination therapy
- hiv aids